The drugs to be approved include: major kinds such as Ormesartan, rizatriptan and Duoxitasai, in addition, more than ten kinds such as Cefpirome still under R&D stage.

• 处于申报阶段的品种有：奥美沙坦、利扎曲坦、多西他赛等重量级品种，此外还有头孢匹罗等十余个品种处于研发阶段。